This episode explores the high-stakes debate over the 340B Drug Pricing Program, analyzing the conflict between safety-net providers and pharmaceutical manufacturers regarding contract pharmacy restrictions, duplicate discounts, and legislative reform.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ilcapitolgroup.substack.com